Pensionfund DSM Netherlands’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Pensionfund DSM Netherlands’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-33,000	Closed	–	–	449
2021 Q4	$0	Hold	33,000	–	–	﹤0.01%	456
2021 Q3	$0	Hold	33,000	–	–	﹤0.01%	484
2021 Q2	$0	Hold	33,000	–	–	﹤0.01%	203
2021 Q1	$0	Hold	33,000	–	–	﹤0.01%	225
2020 Q4	$74K	Hold	33,000	–	–	0.01%	196
2020 Q3	$74K	Hold	33,000	–	–	0.01%	196
2020 Q2	$118K	Hold	33,000	–	–	0.02%	197
2020 Q1	$125K	Hold	33,000	–	–	0.03%	194
2019 Q4	$99K	Buy	+33,000	New	+$85.8K	0.02%	199

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Pensionfund DSM Netherlands's BMY.RT Position: Q1 2022 in Review

Pensionfund DSM Netherlands sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2022, closing a stake of 33,000 shares.

Pensionfund DSM Netherlands first reported a position in BMY.RT in Q4 2019 and held it in 9 quarters. The position peaked at $125K in Q1 2020. 3 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2022.

Pensionfund DSM Netherlands reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2022 after selling out during the quarter.
Pensionfund DSM Netherlands sold 33,000 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2022.
Pensionfund DSM Netherlands first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 9 quarters.
Pensionfund DSM Netherlands's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $125K in Q1 2020.
3 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2022.

Based on Pensionfund DSM Netherlands's 13F filing for Q1 2022, filed 12 Apr 2022.